Prof. Nanshan Zhong is a Medical Professor of Guangzhou Medical University, and a supervisor of respiratory medicine doctoral candidates. He graduated from Beijing Medical College, majoring in medical sciences. He was elected Academician of Chinese Academy of Engineering in 1996, and assumed the posts of President of Chinese Medical Association (2005-2010), Chairman of Guangzhou Association for Science & Technology (till 2012), Director of Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical University (till 2013). Presently, he is the Director-general of China State Key Laboratory of Respiratory Diseases.Prof. Zhong is also a leader and principal investigator to more than 10 major scientific projects, including the State-973, State-863, Tenth State Five-year Plan, National Nature Science Grants, and WHO/GOLD global network. He has published a great number of papers in worldwide reputed SCI journals, including those in New England Journal of Medicine, Nature Medicine, Lancet, BMJ, Am J Respir Crit Care Med, and more than 200 papers in State-level journals. Besides, he has published 16 monographs including Respiratory Medicine (National College Textbooks for Medical Postgraduates), Medicine (National textbooks), Asthma: From Basic to Clinical, etc, and has gained 9 patents.Over the past decades, Prof. Zhong has been a leader scientist in promoting China’s respiratory medicine towards the forefront of international advances. He first developed and refined the definition of asymptomatic asthma. In a systemic review of etiology of chronic cough in China, he elucidated the neuroinflammatory mechanisms to gastroesophageal reflux induced cough. A national epidemiological study steered by him showed for the first time the prevalence of COPD in China. His famous research found that carbocysteine may be effective in preventing or reducing acute exacerbation of COPD. The results of this study were published in a Lancet paper (2008), which was voted as “paper of the year 2008”. He has organized and participated in the development of a number of Chinese guidelines for diagnosis and management of bronchial asthma, COPD, chronic cough, SARS, and high-pathogenic avian flu.